Medline
MDLN
37.04
-0.80
-2.11%
Medline
US · MDLN
#667 by market cap
Listed 2025
37.04
-0.80
-2.11%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Quant vs Street three independent views, side by side
StockVane factor grade
B-
Momentum strategy signal
Sell
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Analyst consensus 17 analysts
Buy
Avg price target 47.64 +28.6%
Price target rangecurrent 37.04
Low44.00
Avg47.64
High55.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-20 | Barclays | -- | Buy | 45.00 |
| 2026-11-13 | Tigress Financial | -- | Buy | 55.00 |
| 2026-11-12 | J.P. Morgan | -- | Buy | 47.00 |
| 2026-11-11 | RBC Capital | -- | Buy | 46.00 |
| 2026-11-09 | BofA Securities | -- | Buy | -- |
| 2026-11-05 | Bernstein | -- | Buy | 49.00 |
| 2026-11-05 | UBS | -- | Buy | 49.00 |
| 2026-11-05 | Baird | -- | Buy | 44.00 |
| 2026-11-05 | Morgan Stanley | -- | Buy | 48.00 |
| 2026-11-05 | Evercore | -- | Buy | 44.00 |
| 2026-11-05 | BMO Capital | -- | Buy | 47.00 |
| 2026-11-05 | Citi | -- | Buy | 47.00 |
| 2026-11-05 | Leerink Partners | -- | Buy | 46.00 |
| 2026-11-04 | Barclays | -- | Buy | 43.00 |
| 2026-11-04 | RBC Capital | -- | Buy | 46.00 |
| 2026-10-22 | Mizuho Securities | -- | Buy | 45.00 |
| 2026-10-09 | Barclays | -- | Buy | 43.00 |
| 2026-10-07 | Leerink Partners | -- | Buy | 43.00 |
| 2026-10-06 | RBC Capital | -- | Buy | 46.00 |
| 2026-09-25 | UBS | -- | Buy | 43.00 |
| 2026-09-23 | William Blair | -- | Buy | -- |
| 2026-09-22 | Truist Financial | -- | Buy | -- |
| 2026-09-16 | Leerink Partners | -- | Buy | 43.00 |
| 2026-09-10 | Leerink Partners | -- | Buy | 34.05 |
| 2026-08-27 | BTIG | -- | Buy | 55.00 |
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-11-04 | -- | ±9.29% | +18.36% (beat) |
| 2026/Q2 | 2026-08-05 | -- | ±11.24% | -12.79% (beat) |
| 2026/Q1 | 2026-05-06 | -- | ±8.24% | -7.30% (in line) |
| 2025/Q4 | 2026-02-25 | -- | ±9.54% | -3.62% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
Medline discussion 0 comments